Alembic Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

2,811.11

2,531.67

2,537.14

2,459.46

2,658.44

Operating profit

373.19

270.92

540.53

513.93

879.49

Interest

29.68

20.75

10.23

6.44

8.42

Gross profit

364.31

251.17

576.83

510.93

874.07

EPS (Rs)

11.77

4.94

22.64

17.76

33.93

Other income

20.80

1.00

46.53

3.45

3.00

Stock adjustment

-37.27

12.49

7.04

11.37

-25.97

Raw material

748.06

608.72

577.69

534.06

579.59

Power and fuel

-

-

-

-

-

Employee expenses

653.87

534.39

499.80

528.39

499.73

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

1,073.26

1,105.15

912.09

871.71

725.60

Provisions made

-

-

-

-

-

Depreciation

132.94

133.56

91.29

88.03

72.55

Taxation

-

20.56

40.60

73.86

134.59

Net profit / loss

231.37

97.05

444.95

349.05

666.93

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

39.31

39.31

39.31

39.31

39.31

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

13.28

10.70

21.30

20.90

33.08

GPM (%)

12.86

9.92

22.33

20.75

32.84

NPM (%)

8.17

3.83

17.22

14.17

25.06